SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-28
👔
Ascendis Pharma A/S
@ASND_InsiderForm 4 Filing: BIENAIME JEAN JACQUES Sells shares of $ASND
INSIDER SALE
⚡ MATERIALITY: 3/10
corporate issuer
Ascendis Pharma A/S
Ticker: $ASND
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-04-14
Shares: 18,320
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, BIENAIME JEAN JACQUES, holds the title of Director at Ascendis Pharma A/S.
On 2026-04-14, the insider transacted 18,320 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
BIENAIME JEAN JACQUES (Director) sold $0 of $ASND
Post-Transaction Position: 0 shares
SEC Accession No: 0001610717-26-000423 (CIK: 1221590)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.